• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶对纤维蛋白原:纤维蛋白转化的体外和体内研究。I. 体外向血浆中添加纤溶酶对乙醇凝胶试验的影响。

Influence of brinase on fibrinogen: fibrin transition in in vitro and in vivo studies. I. Influence of in vitro addition of brinase to plasma on the ethanol gelation test.

作者信息

Frisch E P

出版信息

Haemostasis. 1980;9(1):1-8. doi: 10.1159/000214334.

DOI:10.1159/000214334
PMID:7351312
Abstract

The incidence of positive ethanol gelation test (EGT) after addition of brinase (a proteolytic enzyme preparation from Aspergillus oryzae) to anticoagulated and non-anticoagulated human plasma was studied. In vitro addition of brinase to plasma causes positive EGT, and the incidence is dose-dependent. In plasma from warfarin-treated patients and/or after addition of heparin to plasma, prior to the addition of brinase, a significantly reduced incidence of positive EGT is observed. The incidence is lowest after heparin. Gels formed in the presence of heparin are easier susceptible to enzymatic degradation than those formed in the absence of heparin.

摘要

研究了在抗凝和未抗凝的人血浆中添加米曲霉蛋白酶(一种来自米曲霉的蛋白水解酶制剂)后乙醇凝胶试验(EGT)呈阳性的发生率。在体外向血浆中添加米曲霉蛋白酶会导致EGT呈阳性,且发生率呈剂量依赖性。在华法林治疗患者的血浆中,和/或在向血浆中添加肝素后,在添加米曲霉蛋白酶之前,观察到EGT呈阳性的发生率显著降低。肝素处理后发生率最低。与未添加肝素时形成的凝胶相比,在肝素存在下形成的凝胶更容易被酶降解。

相似文献

1
Influence of brinase on fibrinogen: fibrin transition in in vitro and in vivo studies. I. Influence of in vitro addition of brinase to plasma on the ethanol gelation test.纤溶酶对纤维蛋白原:纤维蛋白转化的体外和体内研究。I. 体外向血浆中添加纤溶酶对乙醇凝胶试验的影响。
Haemostasis. 1980;9(1):1-8. doi: 10.1159/000214334.
2
Influence of brinase on fibrinogen: fibrin transition in vitro and in vivo studies. II. Induction of fibrin deposits by brinase in the kidneys of rats with inhibited fibrinolysis.纤维蛋白溶酶对纤维蛋白原:纤维蛋白转化的体外和体内研究。II. 在纤维蛋白溶解受抑制的大鼠肾脏中纤维蛋白溶酶诱导纤维蛋白沉积
Haemostasis. 1982;11(3):161-9. doi: 10.1159/000214657.
3
Action of brinase on human fibrinogen and plasminogen.
Thromb Haemost. 1979 Aug 31;42(2):571-81.
4
The effect of brinase on fibrinogen in vivo.体内链激酶对纤维蛋白原的作用。
Thromb Diath Haemorrh. 1975 Apr 30;33(2):217-20.
5
Dosage of i.v. brinase in man based on brinase inhibitor capacity and coagulation studies.基于纤维蛋白溶酶抑制剂活性及凝血研究确定的人体静脉注射纤维蛋白溶酶剂量。
Angiology. 1975 Jul-Aug;26(7):557-63. doi: 10.1177/000331977502600708.
6
Effect of brinase (protease I from aspergillus oryzae) on the elimination of fibrin from the lungs and pulmonary damage in rats with induced intravascular coagulation and inhibited fibrinolysis.布瑞纳酶(米曲霉蛋白酶I)对诱导血管内凝血并抑制纤维蛋白溶解的大鼠肺中纤维蛋白清除及肺损伤的影响。
Thromb Res. 1976 Dec;9(6):611-22. doi: 10.1016/0049-3848(76)90108-0.
7
Properties of the complex between alpha 2-macroglobulin and brinase, a proteinase from Aspergillus oryzae with thrombolytic effect.
Thromb Res. 1988 Jan 1;49(1):55-68. doi: 10.1016/0049-3848(88)90359-3.
8
Thrombolytic treatment with i.v. brinase of advanced arterial obliterative disease of the limbs.静脉注射链激酶治疗晚期肢体动脉闭塞性疾病。
Angiology. 1975 Jul-Aug;26(7):534-56. doi: 10.1177/000331977502600707.
9
Clinical pharmacology of the thrombolytic enzyme preparation brinase.溶栓酶制剂布立酶的临床药理学
Semin Thromb Hemost. 1989 Jul;15(3):341-6. doi: 10.1055/s-2007-1002726.
10
Studies of protease and protease inhibitors in familial amyloidotic polyneuropathy.家族性淀粉样多神经病中蛋白酶及蛋白酶抑制剂的研究。
J Neurol Sci. 1987 Oct;81(1):79-84. doi: 10.1016/0022-510x(87)90185-7.